On-column disulfide bond formation of monoclonal antibodies during Protein A chromatography eliminates low molecular weight species and rescues reduced antibodies
Disulfide bond reduction, which commonly occurs during monoclonal antibody (mAb) manufacturing processes, can result in a drug substance with high levels of low molecular weight (LMW) species that may fail release specifications because the drug’s safety and the efficiency may be affected by the pre...
Tallennettuna:
| Päätekijät: | , , , , , , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2020-01-01
|
| Sarja: | mAbs |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/19420862.2020.1829333 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
